STING1 and neoplasm: Studies have performed that the STING agonist (2′3′-cGAMP) could facilitate malignant B-cell apoptosis by phosphorylation and activation of STING on mice fibroblasts; subsequently, the tumor cell antigens are released to stimulate immune response in this manner (Tang et al., 2016).